TYLER ANDREW: Open Payments
NPI 1356109524 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 20 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $84 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $153 |
| ABBVIE INC. | 5 | $115 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Tris Pharma Inc | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Alkermes, Inc. | 1 | $16 |
Products named: CAPLYTA, VRAYLAR, Quviviq, FANAPT, Dyanavel XR, REXULTI, SPRAVATO, Auvelity.
Industry payments across TN — which companies pay providers there.
